Submillimeter-resolution fluorescence laparoscopy of pancreatic cancer in a carcinomatosis mouse model visualizes metastases not seen with standard laparoscopy.

BACKGROUND Staging laparoscopy can visualize peritoneal and liver metastases in pancreatic cancer otherwise undetectable by preoperative imaging. However, false-negative rates may be as high as 18%-26%. The aim of the present study was to improve detection of metastatic pancreatic cancer with the use of fluorescence laparoscopy (FL) in a nude-mouse model with the tumors expressing green fluorescent protein (GFP). METHODS The carcinomatosis mouse model of human pancreatic cancer was established by intraperitoneal injections of green fluorescent protein-expressing MiaPaca-2 human pancreatic cancer cells into 6-week-old female athymic mice. Two weeks later, mice underwent diagnostic laparoscopy. Laparoscopy was performed first under standard brightfield lighting, followed by fluorescent lighting. The number of metastatic foci identified within the four quadrants of the peritoneal cavity was recorded. After laparoscopy, the animals were sacrificed, opened, and imaged with the OV-100 Small Animal Imaging system as a positive control to identify metastasis. Tumors were collected and processed for histologic review. RESULTS FL enabled visualization of pancreatic cancer metastatic foci not visualized with standard brightfield laparoscopy (BL). Under FL, in 1 representative mouse, 26 separate micrometastatic lesions were identified. In contrast, only very large tumors were seen using BL. Use of the OV-100 images, as positive controls, confirmed the presence of tumor foci. FL thus allowed identification and exact localization of submillimeter tumor foci. Such small-sized tumor foci were not distinguished from surrounding tissue under BL. All malignant lesions were histologically confirmed. CONCLUSIONS The use of FL enables the identification of tumor foci that cannot be seen with standard laparoscopy. The technology described in this report has important potential for the clinical development of FL.

[1]  J. Hinshaw,et al.  Staging laparoscopy enhances the detection of occult metastases in patients with pancreatic adenocarcinoma , 2009, Journal of Surgical Oncology.

[2]  Meng Yang,et al.  Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. , 2002, Cancer research.

[3]  W. Schwesinger,et al.  The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Robert M Hoffman,et al.  A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. , 2003, The Journal of surgical research.

[5]  S. Mordon,et al.  Laparoscopic Photodynamic Diagnosis of Ovarian Cancer Peritoneal Micro Metastasis: An Experimental Study , 2007, Photochemistry and photobiology.

[6]  Sharmeela Kaushal,et al.  Fluorescence laparoscopy imaging of pancreatic tumor progression in an orthotopic mouse model , 2010, Surgical Endoscopy.

[7]  Gereon Hüttmann,et al.  Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5‐aminolevulinic acid‐induced protoporphyrin IX , 2004, Cancer.

[8]  J. Riemann,et al.  Improved tumor staging by diagnostic laparoscopy. , 1999, Zeitschrift fur Gastroenterologie.

[9]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[10]  Katsuhiro Hayashi,et al.  In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation , 2009, Proceedings of the National Academy of Sciences.

[11]  Patrick M M Bossuyt,et al.  Laparoscopic Staging and Subsequent Palliation in Patients With Peripancreatic Carcinoma , 2003, Annals of surgery.

[12]  M. Kéramidas,et al.  Intraoperative near‐infrared image‐guided surgery for peritoneal carcinomatosis in a preclinical experimental model , 2010, The British journal of surgery.

[13]  C Herfarth,et al.  Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic fluorescence diagnosis. , 1999, Surgery.

[14]  Sharmeela Kaushal,et al.  Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer , 2008, Journal of Gastrointestinal Surgery.

[15]  Sharmeela Kaushal,et al.  Imaging of Primary and Metastatic Pancreatic Cancer Using a Fluorophore-Conjugated Anti-CA19-9 Antibody for Surgical Navigation , 2008, World Journal of Surgery.